Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Boston Scientific Corporation    BSX

Delayed Quote. Delayed  - 09/30 10:02:57 pm
23.8 USD   +2.15%
09/28 GLOBAL DRUG ELU : BOSTON SCIENTIFIC, JOHNSON and JOHNSON, ABBOTT LAB..
09/28 GLOBAL DRUG DEV : Boston Scientific, Medtronic, Roche Diagnostics, A..
09/28 BOSTON SCIENTIF : will pay $210M for endoscopy maker EndoChoice
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Boston Scientific Corporation : BSX, ABT, ZMH, and ETRM Under StockCall’s Microscope

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/02/2013 | 02:00pm CEST

StockCall.com Provides Stock Research on Boston Scientific Corp., Abbott Laboratories, Zimmer Holdings Inc., and EnteroMedics Inc.

New York City, New York -- (May 02, 2013)

The Supreme Court, last year, upheld the Affordable Care Act (ACA), which is the biggest overhaul of the healthcare industry in decades. While the healthcare industry has generally supported ACA, some features of the act have faced criticism. One such feature is the 2.3% tax on gross U.S. sales of medical devices. Medical appliances & equipment makers say that the tax will lead to higher costs for them, hurting innovation. While the Senate voted in favor of repealing the 2.3% tax, it is unlikely that the tax will be repealed. Shares of medical appliances & equipment companies ended mostly lower on Wednesday, tracking losses in the broad market. Among the major movers were Boston Scientific Corporation (NYSE: BSX), Abbott Laboratories (NYSE: ABT), Zimmer Holdings Inc. (NYSE: ZMH), and EnteroMedics Inc. (NASDAQ: ETRM). StockCall has released full comprehensive research on BSX, ABT, ZMH, and ETRM and these free technical analyses can be downloaded by signing up at

www.stockcall.com/technicalanalysis

Shares of Boston Scientific Corporation fluctuated between gains and losses on Wednesday before finishing the day flat at $7.49 on volume of 12.95 million. Shares of the company have traded sideways this week. However, year-to-date, the stock has had an excellent run, jumping more than 30.70% as compared to a gain of nearly 11% for the S&P 500. BSX?s shares are currently trading nearly 5.80% below their 52-week high. Free technical analysis on BSX available by signing up at

www.StockCall.com/BSX050213.pdf

Shares of Abbott Laboratories edged lower in Wednesday?s trading session, however, the losses were limited. The stock ended the day 0.08% lower at $36.89 on volume of 5.46 million after trading between $36.62 and $37.20. Despite the pullback, Abbott?s shares are up nearly 1.20% for the week. The stock has gained more than 18.50% so far in 2013, outperforming the S&P 500. However, shares of ABT have been struggling to break through $37.50 resistance level. The stock is currently trading well above its 50-day and 200-day moving averages. Register today and access the free research on ABT at

www.StockCall.com/ABT050213.pdf

Zimmer Holdings Inc.?s shares also slipped in trading on Wednesday, tracking losses in the broad market. The stock closed 1.50% lower at $75.30 on volume of 617,800. Despite the pullback, the company?s shares are currently trading close to their 52-week high of $77.53. Shares of ZMH have been facing resistance at around $76.50. The stock currently has strong support at around $73. Zimmer?s shares are currently trading well above their 50-day and 200-day moving averages which suggests that market sentiment is bullish on the stock. The positive trend is further confirmed by recent volume activity. The free report on ZMH can be downloaded by signing up now at

www.StockCall.com/ZMH050213.pdf

Shares of EnteroMedics Inc. tumbled in Wednesday?s trading session after the company reported its financial results for the first quarter. The stock closed 9.59% lower at $0.868 on above average volume of 601,300 after touching an intra-day low of $0.86. Shares of ETRM are currently trading close to their 52-week low of $0.81. Year-to-date, the stock has now fallen nearly 69%. Most of the losses came in mid-February when the stock saw a huge sell-off. EnteroMedics? shares have now slipped below their 50-day moving average. Free report on ETRM can be accessed by registering at

www.StockCall.com/ETRM050213.pdf

About StockCall.com

StockCall.com is a financial website where investors can have easy, precise and comprehensive research and opinions on stocks making the headlines. Sign up today to talk to our financial analyst at

www.stockcall.com

Contact Person:

William T. Knight

Email: info@stockcall.com

Contact Number: (646) 396-9857 (9:00 am EST ? 01:30 pm EST)


© Accesswire 2013
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on BOSTON SCIENTIFIC CORPORAT
09/28 GLOBAL DRUG ELUTING STENTS (DES) MAR : BOSTON SCIENTIFIC, JOHNSON and JOHNSON, A..
09/28 GLOBAL DRUG DEVICE COMBINATION PRODU : Boston Scientific, Medtronic, Roche Diagn..
09/28 BOSTON SCIENTIFIC : will pay $210M for endoscopy maker EndoChoice
09/27 ENDOCHOICE : Boston Scientific buys EndoChoice for $210m
09/27 MEDX : medical incubator opens its doors
09/27DJBOSTON SCIENTIFIC : to Buy EndoChoice
09/27 BOSTON SCIENTIFIC CORP : Other Events, Financial Statements and Exhibits (form 8..
09/24 BOSTON SCIENTIFIC : For medical device makers, return elusive for longer battery..
09/22 BOSTON SCIENTIFIC : $33,350 Federal Contract Awarded to Boston Scientific
09/20 MEDX : medical incubator opens its doors
More news
Sector news : Advanced Medical Equipment & Technology - NEC
09/01DJPHILIPS : Appoints IBM Executive Sophie Bechu as Operations Head
08/17DJAGILENT TECHNOLOGIES : Tech Tapers Annual Outlook Amid Slowing Life Sciences Sal..
08/15DJFisher & Paykel Files Patent Infringement Claim Against ResMed
08/02DJCERNER : Edges Annual Revenue Guidance Lower
07/29DJSony Reports Surprise Profit
More sector news : Advanced Medical Equipment & Technology - NEC
News from SeekingAlpha
09/27 Disney Prepping Twitter Bid
09/27 Boston Scientific acquires platform GI firm EndoChoice for $8 a share
09/19 Game Plan For The Week - Cramer's Mad Money (9/16/16)
09/15 Rox Medical Thrives Under Pressure
09/07 U.S. Deals Dominate Medtech M&A
Advertisement
Financials ($)
Sales 2016 8 311 M
EBIT 2016 1 742 M
Net income 2016 595 M
Debt 2016 4 177 M
Yield 2016 -
P/E ratio 2016 47,07
P/E ratio 2017 23,95
EV / Sales 2016 4,32x
EV / Sales 2017 3,84x
Capitalization 31 705 M
More Financials
Chart BOSTON SCIENTIFIC CORPORAT
Duration : Period :
Boston Scientific Corporat Technical Analysis Chart | BSX | US1011371077 | 4-Traders
Full-screen chart
Technical analysis trends BOSTON SCIENTIFIC...
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 26
Average target price 27,5 $
Spread / Average Target 18%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Michael F. Mahoney Chairman, President & Chief Executive Officer
Edward Mackey Executive Vice President-Operations
Daniel J. Brennan Chief Financial Officer & Executive Vice President
Keith D. Dawkins Global Chief Medical Officer & Executive VP
Nelda J. Connors Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
BOSTON SCIENTIFIC CORP..26.36%31 705
THERMO FISHER SCIENTIF..10.02%61 529
PHILIPS11.84%28 018
INTUITIVE SURGICAL, IN..31.83%27 715
ILLUMINA, INC.-8.02%25 884
EDWARDS LIFESCIENCES C..51.00%25 388
More Results